Dianthus Therapeutics, Inc. /DE/（DNTH）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Dianthus Therapeutics, Inc. /DE/（DNTH）报告了 109 笔 Form 4 交易（最近一笔 2026-09-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 买入 | 20,000 | $357,600 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 7,928 | $796,209 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 6,771 | $686,376 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 3,501 | $358,467 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 1,100 | $113,520 |
| 2026-09-18 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 卖出 | 700 | $73,073 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 卖出 | 2,600 | $273,494 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 买入 | 6,249 | $136,041 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 买入 | 9,375 | $206,906 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 买入 | 7,500 | $134,100 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 卖出 | 7,215 | $766,594 |
| 2026-09-03 | Randhawa Simrat | EVP, Head of R&D | 卖出 | 13,309 | $1.4M |
| 2026-08-19 | Read Simon | 董事 | 卖出 | 2,778 | $326,554 |
| 2026-08-19 | Read Simon | 董事 | 买入 | 2,778 | $51,004 |
| 2026-08-14 | Veness Adam M | SVP, General Counsel and Sec. | 买入 | 15,000 | $272,550 |
| 2026-08-11 | Read Simon | 董事 | 卖出 | 831 | $90,537 |
| 2026-08-11 | Read Simon | 董事 | 买入 | 2,777 | $50,986 |
| 2026-08-11 | Veness Adam M | SVP, General Counsel and Sec. | 买入 | 3,833 | $68,534 |
| 2026-08-11 | McGeorge Anne | 董事 | 买入 | 1,250 | $24,200 |
| 2026-08-11 | Read Simon | 董事 | 卖出 | 70 | $7,498 |
| 2026-08-11 | Veness Adam M | SVP, General Counsel and Sec. | 卖出 | 3,217 | $355,832 |
| 2026-08-11 | McGeorge Anne | 董事 | 买入 | 6,500 | $72,800 |
| 2026-08-11 | Read Simon | 董事 | 卖出 | 737 | $79,721 |
| 2026-08-11 | Veness Adam M | SVP, General Counsel and Sec. | 卖出 | 616 | $68,487 |
| 2026-08-11 | McGeorge Anne | 董事 | 卖出 | 1,450 | $155,991 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18